Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy.
We report the case of a 35-year-old woman with premature ovarian failure that was documented at 29 years of age, who wanted to conceive. Although she failed to respond to high doses of menotropin therapy, she ovulated and conceived after she took an oral contraceptive. The oral contraceptive was used to reduce the elevated level of gonadotropins in an effort to restore receptors to the luteinizing hormone and follicle-stimulating hormone, which theoretically may have been down-regulated.
Check
J H
JH
Department of Obstetrics and Gynecology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA.
Chase
J S
JS
Spence
M
M
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008593:Menopause / Q000187:drug effects*; D008594:Menopause, Premature / Q000187:drug effects*; D008596:Menotropins / Q000627:therapeutic use*; D009640:Norethindrone / Q000627:therapeutic use; D011247:Pregnancy
D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D004958:Estradiol; D008596:Menotropins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009640:Norethindrone